Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
RR

Ralph P. Robinson — 31 Patents

Pfizer: 32 patents #54 of 5,153Top 2%
Gales Ferry, CT: #5 of 101 inventorsTop 5%
Connecticut: #1,066 of 34,797 inventorsTop 4%
Overall (All Time): #115,823 of 4,157,543Top 3%
31 Patents All Time
Ralph P. Robinson has been granted 31 US patents while listed as an inventor at Pfizer. The first was granted in 1993 and the most recent in May 2025. Ralph P. Robinson ranks #115,823 of 4,157,543 US inventors in our database (top 2.8%). Patent records list Ralph P. Robinson in Gales Ferry, CT, US.

Issued Patents All Time

Showing 1–25 of 31 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
12312344 N-substituted-dioxocyclobutenylamino-3-hydroxy-picolinamides useful as CCR6 inhibitors Brian Stephen Gerstenberger, Andrew Christopher Flick, Daniel Wei-Shung Kung, Vincent Michael Lombardo, James John Mousseau +7 more 2025-05-27
12103921 Chemical compounds Ariamala Gopalsamy, Shawn Cabral, Agustin Casimiro Garcia, Ming Zhu Chen, Chulho Choi +10 more 2024-10-01 $338,444,000
11708360 N-substituted-dioxocyclobutenylamino-3-hydroxy-picolinamides useful as CCR6 inhibitors Brian Stephen Gerstenberger, Andrew Christopher Flick, Daniel Wei-Shung Kung, Vincent Michael Lombardo, James John Mousseau +7 more 2023-07-25 $554,221,000
11702405 Chemical compounds Ariamala Gopalsamy, Shawn Cabral, Agustin Casimiro-Garcia, Ming Zhu Chen, Chulho Choi +10 more 2023-07-18 $390,606,000
11014908 Chemical compounds Ariamala Gopalsamy, Arjun Venkat Narayanan, Agustin Casimiro-Garcia, Chulho Choi, David Hepworth +10 more 2021-05-25 $425,301,000
10975065 N-substituted-dioxocyclobutenylamino-3-hydroxy-picolinamides useful as CCR6 inhibitors Brian Stephen Gerstenberger, Andrew Christopher Flick, Vincent Michael Lombardo, James John Mousseau, Philippe Marcel Nuhant +7 more 2021-04-13 $1,297,023,000
8635860 Internal combustion engine heat transfer system 2014-01-28
7553877 Modulators of the glucocorticoid receptor Yves Chantigny, Edward F. Kleinman 2009-06-30 $258,331,000
7468378 Substituted quinoline compounds Peter Bertinato, Michel A. Couturier, Ernest S. Hamanaka, Marcus Ewing, Derek Tickner 2008-12-23 $147,873,000
7393958 Triamide-substituted heterobicyclic compounds Peter Bertinato, Michel A. Couturier, Ernest S. Hamanaka, Marcus Ewing, Derek Tickner 2008-07-01 $232,894,000
7368573 Triamide-substituted heterobicyclic compounds Peter Bertinato, Michel A. Couturier, Ernest S. Hamanaka, Marcus Ewing, Derek Tickner 2008-05-06 $143,522,000
7138406 Modulators of the glucocorticoid receptor Yves Chantigny, Edward F. Kleinman 2006-11-21 $296,227,000
6852719 Glucocorticoid receptor modulators Kevin Liu, Bradley P. Morgan 2005-02-08 $111,158,000
6458822 2-oxo-imidazolidine-4-carboxylic acid hydroxamide compounds that inhibit matrix metalloproteinases Ellen Laird 2002-10-01 $404,760,000
6380219 Arylsulfonylamino hydroxamic acid derivatives James P. Rizzi 2002-04-30 $143,968,000
6303636 Arylsulfonylamino hydroxamic acid derivatives Kim F. McClure 2001-10-16 $419,221,000
6214870 Dioxocyclopentyl hydroxamic acids Kim F. McClure 2001-04-10 $1,296,256,000
6214872 Aryloxyarylsulfonylamino hydroxamic acid derivatives 2001-04-10 $1,296,256,000
6153609 Arylsulfonylamino hydroxamic acid derivatives Todd A. Blumenkopf 2000-11-28 $1,018,671,000
6147074 Arylsulfonylamino hydroxamic acid derivatives James P. Rizzi 2000-11-14 $473,136,000
6114361 5-oxo-pyrrolidine-2-carboxylic acid hydroxamide derivatives Ellen Laird 2000-09-05 $418,382,000
6110964 Bicyclic hydroxamic acid derivatives 2000-08-29 $295,433,000
6107337 Arylsulfonylamino hydroxamic acid derivatives 2000-08-22 $440,456,000
5994351 Arylsulfonylamino hydroxamic acid derivatives James P. Rizzi 1999-11-30 $257,939,000
5863949 Arylsulfonylamino hydroxamic acid derivatives James P. Rizzi 1999-01-26 $624,841,000